The failure of biological treatment in axial spondyloarthritis is linked to the factors related to increased intestinal permeability and dysbiosis: prospective observational cohort study
Rheumatology International · 2024
DOI: 10.1007/s00296-024-05614-4 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Rheumatology International, 2024. Verfasst von Magdalena Chmielińska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, Physiology and Pathophysiology, Faculty of Health Sciences, Medical University of Warsaw, 02-004, Warsaw, Poland. m.chmieli…. Hauptthemen laut MEDLINE: Axial Spondyloarthritis, Cholera Toxin, Dysbiosis, Haptoglobins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
A significant number of patients with axial spondyloarthritis (axSpA) do not respond to biological therapy. Therefore, we decided to investigate the specificity of this group of patients and, in particular, whether haptoglobin (Hp), its polymorphism and zonulin, in addition to other clinical features, are predictors of poor response to biological treatment.
Methods
48 patients with axSpA who were unsuccessfully treated with standard drugs were converted to biological treatment, and from this time on, a 12-week follow-up was started to assess the failure of biological treatment (Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) decrease < 2 points). Predictors of treatment failure were identified using logistic regression analysis.
Results
21% of subjects had biological treatment failure. Patients who had a higher zonulin level, a history of frequent infections, were older, had inflammatory bowel disease (IBD), had a lower Hp level at the time of inclusion in biological therapy showed an increased risk of treatment failure.
Conclusions
The results of the study support the hypothesis that the effectiveness of biological treatment of axSpA is limited by changed microbiota and intestinal epithelial barrier dysfunction, as an increased risk of biological treatment failure was observed in patients who were older, had higher zonulin level, IBD and repeated courses of antibiotics due to frequent infections. Therefore, starting biological treatment should be followed by reducing intestinal permeability and regulating the disturbed gut microbiome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biophysics, Physiology and Pathophysiology, Faculty of Health Sciences, Medical University of Warsaw, 02-004, Warsaw, Poland. m.chmielinskaa@gmail.com.
- Department of Outpatient Clinics, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637, Warsaw, Poland. m.chmielinskaa@gmail.com.
- Biologic Therapy Center, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637, Warsaw, Poland.
- Department of Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637, Warsaw, Poland.
- Department of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637, Warsaw, Poland.
- Department of Biophysics, Physiology and Pathophysiology, Faculty of Health Sciences, Medical University of Warsaw, 02-004, Warsaw, Poland.
ORCID-Profile: Magdalena Chmielińska, Anna Felis-Giemza, Marzena Olesińska, Agnieszka Paradowska-Gorycka, Dariusz Szukiewicz
Zitieren
APA
Chmielińska, M., Felis-Giemza, A., Olesińska, M., Paradowska-Gorycka, A., & Szukiewicz, D. (2024). The failure of biological treatment in axial spondyloarthritis is linked to the factors related to increased intestinal permeability and dysbiosis: prospective observational cohort study. Rheumatology International. https://doi.org/10.1007/s00296-024-05614-4
Vancouver
Chmielińska M, Felis-Giemza A, Olesińska M, Paradowska-Gorycka A, Szukiewicz D. The failure of biological treatment in axial spondyloarthritis is linked to the factors related to increased intestinal permeability and dysbiosis: prospective observational cohort study. Rheumatology International. 2024. doi:10.1007/s00296-024-05614-4
BibTeX
@article{Chmieliska2024,
author = {Chmielińska, Magdalena and Felis-Giemza, Anna and Olesińska, Marzena and Paradowska-Gorycka, Agnieszka and Szukiewicz, Dariusz},
title = {The failure of biological treatment in axial spondyloarthritis is linked to the factors related to increased intestinal permeability and dysbiosis: prospective observational cohort study},
journal = {Rheumatology International},
year = {2024},
doi = {10.1007/s00296-024-05614-4}
}
EUVIMED